Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Multilayer Model for Early Detection of COVID-19

View ORCID ProfileErez Shmueli, Ronen Mansuri, Matan Porcilan, Tamar Amir, Lior Yosha, Matan Yechezkel, Tal Patalon, Sharon Handelman-Gotlib, Sivan Gazit, Dan Yamin
doi: https://doi.org/10.1101/2021.02.25.21252470
Erez Shmueli
1Department of Industrial Engineering, Tel-Aviv University, Tel-Aviv 69978, Israel
2MIT Media Lab, Cambridge, MA 02139-4307, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erez Shmueli
  • For correspondence: shmueli{at}tau.ac.il
Ronen Mansuri
1Department of Industrial Engineering, Tel-Aviv University, Tel-Aviv 69978, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matan Porcilan
1Department of Industrial Engineering, Tel-Aviv University, Tel-Aviv 69978, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamar Amir
1Department of Industrial Engineering, Tel-Aviv University, Tel-Aviv 69978, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lior Yosha
1Department of Industrial Engineering, Tel-Aviv University, Tel-Aviv 69978, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matan Yechezkel
1Department of Industrial Engineering, Tel-Aviv University, Tel-Aviv 69978, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tal Patalon
3Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Handelman-Gotlib
3Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sivan Gazit
3Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Yamin
1Department of Industrial Engineering, Tel-Aviv University, Tel-Aviv 69978, Israel
4Center for Combatting Pandemics, Tel Aviv University, Tel Aviv 6997801, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Current efforts for COVID-19 screening mainly rely on reported symptoms and potential exposure to infected individuals. Here, we developed a machine-learning model for COVID-19 detection that utilizes four layers of information: 1) sociodemographic characteristics of the tested individual, 2) spatiotemporal patterns of the disease observed near the testing episode, 3) medical condition and general health consumption of the tested individual over the past five years, and 4) information reported by the tested individual during the testing episode. We evaluated our model on 140,682 members of Maccabi Health Services, tested for COVID-19 at least once between February and October 2020. These individuals had 264,516 COVID-19 PCR-tests, out of which 16,512 were found positive. Our multilayer model obtained an area under the curve (AUC) of 81.6% when tested over all individuals, and of 72.8% when tested over individuals who did not report any symptom. Furthermore, considering only information collected before the testing episode – that is, before the individual may had the chance to report on any symptom – our model could reach a considerably high AUC of 79.5%. Namely, most of the value contributed by the testing episode can be gained by earlier information. Our ability to predict early the outcomes of COVID-19 tests is pivotal for breaking transmission chains, and can be utilized for a more efficient testing policy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The research was supported by the Israel Science Foundation (grant No. 3409/19) within the Israel Precision Medicine Partnership program, and the European Research Council (ERC) project \#949850. The funders has no role in the design of the study, collection, analysis, and interpretation of data.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by MHS' Helsinki institutional review board, protocol number 0093-20-MHS, signed on October 21, 2020. Informed consent was waived as identifying details were removed before the analysis.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Access to the data used for this study can be made available upon request and is subject to internal review approval from the institutional review board of MHS with the current data sharing guidelines of MHS and Israeli law.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 01, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Multilayer Model for Early Detection of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Multilayer Model for Early Detection of COVID-19
Erez Shmueli, Ronen Mansuri, Matan Porcilan, Tamar Amir, Lior Yosha, Matan Yechezkel, Tal Patalon, Sharon Handelman-Gotlib, Sivan Gazit, Dan Yamin
medRxiv 2021.02.25.21252470; doi: https://doi.org/10.1101/2021.02.25.21252470
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Multilayer Model for Early Detection of COVID-19
Erez Shmueli, Ronen Mansuri, Matan Porcilan, Tamar Amir, Lior Yosha, Matan Yechezkel, Tal Patalon, Sharon Handelman-Gotlib, Sivan Gazit, Dan Yamin
medRxiv 2021.02.25.21252470; doi: https://doi.org/10.1101/2021.02.25.21252470

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)